Emergent BioSolutions Inc.

EBS

NYSE

Healthcare

Drug Manufacturers - Specialty & Generic

Gaithersburg, MD, US900 employeesemergentbiosolutions.com

$8.20

-0.18(-2.15%)

Mkt Cap $425M

$4.26

$13.90

52-Week Range

At A Glance

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threa...

Revenue is primarily driven by Medical Countermeasures MCM Product (32.8%) and Product And Service (32.4%).

Most recently: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment o (2026-03-03).

$425M

Market Cap

$729M

Revenue

$52M

Net Income

Employees900

Fundamentals

How The Business Makes Money

Revenue by Segment

Medical Countermeasures MCM Product32.8%($2.8B)

Product And Service32.4%($2.8B)

Commercial Product26.1%($2.2B)

All Other Revenue7.5%($650M)

Contracts And Grants1.1%($94M)

Revenue by Geography

US69.1%($2.0B)

CA15.5%($440M)

Other Geographical Area15.4%($435M)

Activity

What Changed Recently

Management Change

Mar 2, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment o

Financial Results

Feb 25, 2026

. Results of Operations and Financial Condition. On February 26, 2026, Emergent BioSolutions Inc. (the "Company") issued a press release (the "Press Release") a

Regulation FD

Jan 13, 2026

, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act or into any fi

Regulation FD

Jan 11, 2026

and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorp

Peer Companies

Company	Price	Change	Market Cap	P/E
OLMAOlema Pharmaceuticals, In...	$15.11	-0.10%	$1.3B	-7.9
CRVSCorvus Pharmaceuticals, I...	$14.74	+2.18%	$1.2B	-71.0
CMPSCOMPASS Pathways plc	$5.76	+2.58%	$554M	-2.1
ESPREsperion Therapeutics, In...	$2.62	+0.19%	$544M	-27.3
PRTAProthena Corporation plc	$9.82	-2.09%	$529M	-1.9
RIGLRigel Pharmaceuticals, In...	$27.56	+0.22%	$509M	1.3
AQSTAquestive Therapeutics, I...	$4.14	+0.24%	$411M	-5.7
SIGASIGA Technologies, Inc.	$5.22	+1.06%	$374M	—

Analyst View

Company Profile

CIK0001367644

ISINUS29089Q1058

CUSIP29089Q105

Phone240 631 3200

Address400 Professional Drive, Gaithersburg, MD, 20879, US

SEC EDGAR